• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用稳定同位素标记的甘油和油酸区分 DGAT1 和 -2 的肝功能。

The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.

机构信息

Cardiovascular and Metabolic Disease Research and Community of Research Excellence and Advanced Technology, Janssen Pharmaceutical Companies of Johnson and Johnson, Spring House, PA 19477, USA.

出版信息

J Lipid Res. 2012 Jun;53(6):1106-16. doi: 10.1194/jlr.M020156. Epub 2012 Apr 3.

DOI:10.1194/jlr.M020156
PMID:22493088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3351817/
Abstract

Diacylglycerol acyltransferase (DGAT) catalyzes the final step in triglyceride (TG) synthesis. There are two isoforms, DGAT1 and DGAT2, with distinct protein sequences and potentially different physiological functions. To date, the ability to determine clear functional differences between DGAT1 and DGAT2, especially with respect to hepatic TG synthesis, has been elusive. To dissect the roles of these two key enzymes, we pretreated HepG2 hepatoma cells with (13)C(3)-D(5)-glycerol or (13)C(18)-oleic acid, and profiled the major isotope-labeled TG species by liquid chromatography tandem mass spectrometry. Selective DGAT1 and DGAT2 inhibitors demonstrated that (13)C(3)-D(5)-glycerol-incorporated TG synthesis was mediated by DGAT2, not DGAT1. Conversely, (13)C(18)-oleoyl-incorporated TG synthesis was predominantly mediated by DGAT1. To trace hepatic TG synthesis and VLDL triglyceride (VLDL-TG) secretion in vivo, we administered D(5)-glycerol to mice and measured plasma levels of D(5)-glycerol-incorporated TG. Treatment with an antisense oligonucleotide (ASO) to DGAT2 led to a significant reduction in D(5)-glycerol incorporation into VLDL-TG. In contrast, the DGAT2 ASO had no effect on the incorporation of exogenously administered (13)C(18)-oleic acid into VLDL-TG. Thus, our results indicate that DGAT1 and DGAT2 mediate distinct hepatic functions: DGAT2 is primarily responsible for incorporating endogenously synthesized FAs into TG, whereas DGAT1 plays a greater role in esterifying exogenous FAs to glycerol.

摘要

二酰基甘油酰基转移酶(DGAT)催化甘油三酯(TG)合成的最后一步。有两种同工酶,DGAT1 和 DGAT2,具有不同的蛋白质序列,可能具有不同的生理功能。迄今为止,确定 DGAT1 和 DGAT2 之间明确的功能差异的能力,特别是在肝 TG 合成方面,一直难以捉摸。为了剖析这两种关键酶的作用,我们用(13)C(3)-D(5)-甘油或(13)C(18)-油酸预处理 HepG2 肝癌细胞,并通过液相色谱串联质谱法对主要同位素标记的 TG 物种进行了分析。选择性 DGAT1 和 DGAT2 抑制剂表明,(13)C(3)-D(5)-甘油掺入的 TG 合成是由 DGAT2 介导的,而不是由 DGAT1 介导的。相反,(13)C(18)-油酰基掺入的 TG 合成主要由 DGAT1 介导。为了追踪体内肝 TG 合成和 VLDL 甘油三酯(VLDL-TG)分泌,我们给小鼠注射 D(5)-甘油,并测量血浆中 D(5)-甘油掺入的 TG 水平。用 DGAT2 的反义寡核苷酸(ASO)处理导致 D(5)-甘油掺入 VLDL-TG 显著减少。相比之下,DGAT2 ASO 对外源性给予的(13)C(18)-油酸掺入 VLDL-TG 没有影响。因此,我们的结果表明,DGAT1 和 DGAT2 介导不同的肝功能:DGAT2 主要负责将内源性合成的 FA 掺入 TG,而 DGAT1 在酯化外源性 FA 到甘油方面发挥更大的作用。

相似文献

1
The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.利用稳定同位素标记的甘油和油酸区分 DGAT1 和 -2 的肝功能。
J Lipid Res. 2012 Jun;53(6):1106-16. doi: 10.1194/jlr.M020156. Epub 2012 Apr 3.
2
High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity.用于评估细胞和肝酰基辅酶 A 二酰基甘油酰基转移酶活性的高内涵测定法。
J Lipid Res. 2010 Dec;51(12):3559-67. doi: 10.1194/jlr.D008029. Epub 2010 Aug 28.
3
Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells.二酰基甘油酰基转移酶 2 在二酰基甘油酰基转移酶 1 的上游起作用,并在 HepG2 细胞中利用新生的二酰基甘油和从头合成的脂肪酸。
FEBS J. 2012 Sep;279(17):3033-47. doi: 10.1111/j.1742-4658.2012.08684.x. Epub 2012 Jul 31.
4
Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice.用反义寡核苷酸敲低酰基辅酶A:二酰甘油酰基转移酶2可减少小鼠极低密度脂蛋白甘油三酯和载脂蛋白B的分泌。
Biochim Biophys Acta. 2008 Mar;1781(3):97-104. doi: 10.1016/j.bbalip.2008.01.001. Epub 2008 Jan 17.
5
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.用反义寡核苷酸抑制二酰甘油酰基转移酶-2(DGAT2)而非DGAT1,可逆转饮食诱导的肝脂肪变性和胰岛素抵抗。
J Biol Chem. 2007 Aug 3;282(31):22678-88. doi: 10.1074/jbc.M704213200. Epub 2007 May 27.
6
Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1.肝脏中过表达二酰甘油酰基转移酶1(DGAT1)的小鼠,其极低密度脂蛋白分泌增加且性腺脂肪量增多。
J Biol Chem. 2005 Jun 3;280(22):21506-14. doi: 10.1074/jbc.M412989200. Epub 2005 Mar 29.
7
Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production.DGAT1或DGAT2的短期过表达会增加肝脏甘油三酯,但不会增加极低密度脂蛋白甘油三酯或载脂蛋白B的生成。
J Lipid Res. 2006 Oct;47(10):2297-305. doi: 10.1194/jlr.M600213-JLR200. Epub 2006 Jul 30.
8
Preferential lipolysis of DGAT1 over DGAT2 generated triacylglycerol in Huh7 hepatocytes.DGAT1 对 DGAT2 的优先脂肪分解导致 Huh7 肝细胞中的三酰基甘油生成。
Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Oct;1868(10):159376. doi: 10.1016/j.bbalip.2023.159376. Epub 2023 Jul 28.
9
Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2.肝脏 VLDL 分泌:DGAT1 决定颗粒大小而非颗粒数量,而颗粒数量可以完全由 DGAT2 提供。
J Lipid Res. 2019 Jan;60(1):111-120. doi: 10.1194/jlr.M089300. Epub 2018 Nov 5.
10
Role of diacylglycerol O-acyltransferase (DGAT) isoforms in bovine hepatic fatty acid metabolism.二酰甘油 O-酰基转移酶(DGAT)同工酶在牛肝脏脂肪酸代谢中的作用。
J Dairy Sci. 2022 Apr;105(4):3588-3600. doi: 10.3168/jds.2021-21140. Epub 2022 Feb 16.

引用本文的文献

1
A Conserved N-Terminal Di-Arginine Motif Stabilizes Plant DGAT1 and Modulates Lipid Droplet Organization.一个保守的N端双精氨酸基序稳定植物二酰甘油酰基转移酶1并调节脂滴组织。
Int J Mol Sci. 2025 Jul 31;26(15):7406. doi: 10.3390/ijms26157406.
2
Multi-omics analysis revealed the addiction to glutamine and susceptibility to de novo lipogenesis of endometrial neoplasm.多组学分析揭示了子宫内膜肿瘤对谷氨酰胺的依赖以及对从头脂肪生成的易感性。
Sci China Life Sci. 2025 Jul 24. doi: 10.1007/s11427-024-2761-y.
3
Zebrafish are resilient to the loss of major diacylglycerol acyltransferase enzymes.斑马鱼对主要二酰基甘油酰基转移酶的缺失具有耐受性。
J Biol Chem. 2024 Dec;300(12):107973. doi: 10.1016/j.jbc.2024.107973. Epub 2024 Nov 6.
4
Challenges of Spatially Resolved Metabolism in Cancer Research.癌症研究中空间分辨代谢的挑战
Metabolites. 2024 Jul 11;14(7):383. doi: 10.3390/metabo14070383.
5
Differences in diacylglycerol acyltransferases expression patterns and regulation cause distinct hepatic triglyceride deposition in fish.二酰甘油酰基转移酶表达模式和调控的差异导致鱼类肝脏中甘油三酯的沉积存在明显差异。
Commun Biol. 2024 Apr 19;7(1):480. doi: 10.1038/s42003-024-06022-x.
6
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond.探索代谢相关脂肪性肝病的多维度图景:从病理生理学到类器官及其他领域的近期研究综合概述
Biomedicines. 2024 Feb 8;12(2):397. doi: 10.3390/biomedicines12020397.
7
Oleic acid differentially affects lipid droplet storage of synthesized lipids in hepatocytes and adipocytes.油酸对肝细胞和脂肪细胞合成脂质的脂滴储存有差异影响。
Chem Commun (Camb). 2024 Mar 14;60(23):3138-3141. doi: 10.1039/d3cc04829b.
8
Pharmacologic inhibition of lipogenesis for the treatment of NAFLD.通过药物抑制脂肪生成来治疗非酒精性脂肪性肝病。
J Hepatol. 2024 Feb;80(2):362-377. doi: 10.1016/j.jhep.2023.10.042. Epub 2023 Nov 15.
9
Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells.细胞外基质调节人胚胎干细胞来源的肝样细胞的空间肝特征。
Stem Cell Res Ther. 2023 Nov 1;14(1):314. doi: 10.1186/s13287-023-03542-x.
10
Oleic acid differentially affects lipogenesis in adipocytes and hepatocytes.油酸对脂肪细胞和肝细胞的脂肪生成有不同影响。
bioRxiv. 2023 Oct 6:2023.10.04.560581. doi: 10.1101/2023.10.04.560581.

本文引用的文献

1
Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells.证据表明二酰基甘油酰基转移酶 1(DGAT1)在 HepG2 细胞的内质网中有双重膜拓扑结构。
J Biol Chem. 2011 Oct 21;286(42):36238-47. doi: 10.1074/jbc.M111.251900. Epub 2011 Aug 16.
2
The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species.使用稳定同位素标记的油酸来研究体内脂质组装:评估临床前物种中的药理学效应。
J Lipid Res. 2011 Jun;52(6):1150-1161. doi: 10.1194/jlr.M011049. Epub 2011 Mar 17.
3
High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity.用于评估细胞和肝酰基辅酶 A 二酰基甘油酰基转移酶活性的高内涵测定法。
J Lipid Res. 2010 Dec;51(12):3559-67. doi: 10.1194/jlr.D008029. Epub 2010 Aug 28.
4
Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.酰基辅酶A:二酰甘油酰基转移酶1(Dgat1)在外源性脂肪酸导致的肝脂肪变性中的特定作用。
Hepatology. 2009 Aug;50(2):434-42. doi: 10.1002/hep.22980.
5
Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.专题综述系列:甘油脂质。二酰甘油酰基转移酶(DGAT)与三酰甘油生物合成
J Lipid Res. 2008 Nov;49(11):2283-301. doi: 10.1194/jlr.R800018-JLR200. Epub 2008 Aug 29.
6
Diacylglycerol acyltransferases: Potential roles as pharmacological targets.二酰甘油酰基转移酶:作为药理学靶点的潜在作用。
Pharmacol Ther. 2008 Jun;118(3):295-302. doi: 10.1016/j.pharmthera.2008.03.010. Epub 2008 Apr 11.
7
Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice.用反义寡核苷酸敲低酰基辅酶A:二酰甘油酰基转移酶2可减少小鼠极低密度脂蛋白甘油三酯和载脂蛋白B的分泌。
Biochim Biophys Acta. 2008 Mar;1781(3):97-104. doi: 10.1016/j.bbalip.2008.01.001. Epub 2008 Jan 17.
8
Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor.使用一种强效且选择性的小分子抑制剂验证二酰甘油酰基转移酶I作为治疗肥胖症和血脂异常的新靶点。
J Med Chem. 2008 Feb 14;51(3):380-3. doi: 10.1021/jm7013887. Epub 2008 Jan 10.
9
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.用反义寡核苷酸抑制二酰甘油酰基转移酶-2(DGAT2)而非DGAT1,可逆转饮食诱导的肝脂肪变性和胰岛素抵抗。
J Biol Chem. 2007 Aug 3;282(31):22678-88. doi: 10.1074/jbc.M704213200. Epub 2007 May 27.
10
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.抑制甘油三酯合成可改善非酒精性脂肪性肝炎肥胖小鼠的肝脂肪变性,但会加重肝损伤和肝纤维化。
Hepatology. 2007 Jun;45(6):1366-74. doi: 10.1002/hep.21655.